53 non-listed pharmaceutical companies were identified to record current flow of 160%

According to the audit report of 53 non-listed pharmaceutical companies which is submitted to Financial Supervisory Service in 2013, it was identified that their current flow was an average of 160%.

Among the 53 companies surveyed, 15 companies recorded current flow of more than 200%. Therefore, 3 out of 10 non-listed pharmaceutical companies were analyzed to have favorable availability to mob...